Press Releases

February 23, 2022

ChromaCode’s Emergency Use Authorization (EUA) Expanded by FDA for High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

Over six million tests have been performed and analyzed using the HDPCR™ SARS-CoV-2 EUA assay and ChromaCode Cloud™ CARLSBAD, Calif. – February 23, 2022 – ChromaCode, Inc., a […]
August 11, 2021

ChromaCode Adds Industry Leaders, Pat Balthrop and Kevin O’Boyle, to Board of Directors

Carlsbad, Calif. August 11, 2021 – ChromaCode, Inc., a company that combines data science and proprietary reagents to improve clinical molecular analysis, today announced that Patrick Balthrop, […]
March 16, 2021

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

CARLSBAD, Calif., March 16, 2021 — ChromaCode, Inc. today announced that the company has been selected as a Main Track Winning Team in the XPRIZE Rapid […]
March 3, 2021

ChromaCode Core HDPCR Technology Reaches a New Milestone

New Study in the Journal Analytical Chemistry Demonstrates 20-Plex Capabilities Enabling 5x the Potential Analytical Capacity of Standard PCR Instrumentation CARLSBAD, Calif. – March 03, 2021 […]
December 22, 2020

ChromaCode Named Finalist in XPRIZE Rapid Covid Testing Competition

XPRIZE imagines a future where anyone, anywhere, can receive a fast, frequent, cheap and easy COVID-19 test CARLSBAD, Calif., Dec. 22, 2020 /PRNewswire/ — ChromaCode, Inc. today announced […]
June 10, 2020

FDA Issues Emergency Use Authorization for ChromaCode’s High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

High-Definition PCR SARS-CoV-2 assay increases test throughput and reduces complexity of interpretation; ChromaCode customers enjoy inventory guarantee CARLSBAD, Calif. – June 10, 2020 – ChromaCode, Inc., a […]
May 19, 2020

ChromaCode Raises $10 Million Series C Financing From Adjuvant Capital

Funding Will Accelerate the Development of ChromaCode Assays for Infectious Disease, Targeted Toward Resource-Limited Communities Worldwide CARLSBAD, Calif. – May 19, 2020 – ChromaCode, Inc., a company […]
April 21, 2020

ChromaCode Launches High-Throughput HDPCR™ SARS-CoV-2 Assay

ChromaCode joining fight against novel coronavirus; High-Definition PCR SARS-CoV-2 assay to increase test throughput and reduce complexity of interpretation CARLSBAD, Calif. – April 21, 2020 – ChromaCode, Inc., […]
December 17, 2019

ChromaCode Raises $28 Million in Series C Financing

CARLSBAD, Calif., December 17, 2019 /PRNewswire/ — ChromaCode, Inc., a molecular diagnostics company, announced it has closed a $28 million Series C financing round.  The round was led by Northpond […]